ZVRA GlobeNewswire a day ago Zevra Therapeutics to Present Multiple Analyses on MIPLYFFA® at the 22nd Annual WORLDSymposium™
ZVRA Simply Wall St. 3 days ago Investing in Zevra Therapeutics (NASDAQ:ZVRA) three years ago would have delivered you a 63% gain ➖ AI Sentiment Neutral 5/10